59 results
Page 2 of 3
8-K
EX-99.1
z10fjlf3
5 May 22
Axcella Reports First Quarter Financial Results and Provides Business Update
7:41am
8-K
EX-99.1
brsfz5zwh6i46
30 Mar 22
Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:05am
424B5
fef9o
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
h1xqf cogmwwvn0hqtr0
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-99.1
k68f0afev7rv25e cil
10 Jan 22
Other Events
8:00am
8-K
EX-99.1
3j4t pnzq3
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-99.1
czmti9sc 6dma
10 Nov 21
Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
8:08am
8-K
EX-99.1
46qpt q32u
29 Jul 21
Axcella Reports Second Quarter Financial Results and Provides Business Update
7:58am
8-K
EX-99.2
9da1821oh8zwm7ds97
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
qc1df2uc b5ine
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
1kax7 0yynp
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
EX-99.1
w8nkt
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-99.1
v9geua
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am